Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study on the Effects of Bexicaserin for Treating Seizures in Children and Adults with Dravet Syndrome
BelgiumStudy on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
BelgiumLong-term safety study of zagociguat tablets in patients with MELAS syndrome (Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) who completed previous trial
GermanyStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis
AustriaStudy of CVN424 for Reducing Motor Complications in Parkinson's Disease Patients
CzechiaStudy on the Long-term Safety of Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
BelgiumStudy on the Safety and Effects of ALN-APP for Patients with Cerebral Amyloid Angiopathy
The NetherlandsStudy on the Safety and Effectiveness of Vorasidenib and Temozolomide for Patients with IDH1 or IDH2 Mutant Glioma
AustriaStudy on the Effectiveness of Optune with Temozolomide and Pembrolizumab in Patients with Newly Diagnosed Glioblastoma
CzechiaStudy on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis
AustriaStudy on Diclofenac Potassium and Rimegepant for Treating Migraine in Patients
DenmarkLong-Term Safety Study of ST-920 Gene Therapy for Patients with Fabry Disease
GermanyThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
